Viewing Study NCT06362720


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-03-16 @ 8:34 AM
Study NCT ID: NCT06362720
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-12
First Post: 2024-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based Regimen
Sponsor: Siriraj Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None CMV Infection or Reactivation After Allogenic HSCT View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CMV infection View
None CMV reactivation View
None allogenic HSCT View
None GVHD prophylaxis View
None posttransplant cyclophosphamide (PTCy) View
None cyclosporin A View
None methotrexate View